Table 4.
Predictive value of CHD1 deletion for cancer-specific survival (multivariate cause-specific cox proportional hazards model, n = 6831, events = 124).
| HR | 95% CI | P value | |
|---|---|---|---|
| CHD1 (del. vs norm.) | 1.66 | [1.03, 2.68] | 0.037 |
| Age [per 10 years] | 0.80 | [0.59, 1.08] | 0.149 |
| BCR (yes vs no) | 4.40 | [2.42, 8.03] | <0.001 |
| Gleason Group | <0.001 | ||
| 3 + 4 vs ≤3 + 3 | 2.00 | [0.85, 4.70] | 0.111 |
| 4 + 3 vs ≤3 + 3 | 5.09 | [2.05, 12.65] | <0.001 |
| ≥4 + 4 vs ≤3 + 3 | 17.86 | [6.80, 46.85] | <0.001 |
| pN status | 0.364 | ||
| Nx vs N0 | 1.01 | [0.57, 1.80] | 0.969 |
| N+ vs N0 | 1.41 | [0.88, 2.27] | 0.156 |
| PSA [per 10 units] | 1.06 | [0.97, 1.15] | 0.209 |
| Surgical margin (pos vs neg) | 1.78 | [1.22, 2.59] | 0.003 |
| pT stage | <0.001 | ||
| pT3a vs pT2 | 0.83 | [0.44, 1.57] | 0.575 |
| pT3b/pT4 vs pT2 | 2.17 | [1.20, 3.93] | 0.010 |
![]() |
